Generic Reglan is used for short-term treatment of gastroesophageal reflux disease (GERD) in certain patients who do not respond to other therapy. It is used to treat symptoms of a certain digestive problem in diabetic patients (diabetic gastroparesis). More info »
Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order.
- Dave
MD News (press release)Olanzapine Beats Metoclopramide For Chemo NauseaMD News (press release)For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment with metoclopramide.
IV Prochlorperazine Effective for Pediatric Primary Intractable Migraine - Monthly Prescribing Reference
IV Prochlorperazine Effective for Pediatric Primary Intractable MigraineMonthly Prescribing ReferenceHONOLULU, HI—Intravenous (IV) prochlorperazine is more effective for the acute treatment of refractory migraine in pediatric patients than IV metoclopramide or valproate sodium.
Anti-psychotic drug reduces chemo effects - UPI.com
Anti-psychotic drug reduces chemo effectsUPI.
Three states, one drug, and a Supreme Court ruling - Thomson Reuters News & Insight
Thomson Reuters News & InsightThree states, one drug, and a Supreme Court rulingThomson Reuters News & InsightAs you may recall, Reglan, or metoclopramide, was the drug at issue in the high court.
Olanzapine Proves Effective in Breakthrough CINV - OncLive
OncLiveOlanzapine Proves Effective in Breakthrough CINVOncLiveThese participants were then randomized to receive either olanzapine at a dose of 10 mg orally daily for three days or metoclopramide at a dose of 10 mg orally three times daily for three days.